Marina Talamonti

42PUBLICATIONS
92CO-AUTHORS
Gene and molecular therapyAllergyPharmacogenomicsDisease surveillanceEpidemiological modelling
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (42)

|Jul 28, 2026
Treatment Switching and Drug Survival of Biologic Therapies in Psoriasis: A Real-World Italian Study Across Biologic Classes.

|Feb 19, 2026
Psychological Well-Being of Patients with Moderate-to-Severe Plaque Psoriasis Treated with Tildrakizumab: 28-Week Interim Results from a Multicenter Observational Study in Italy Using the DASS-21 Questionnaire, the BLUE Study.

Emanuele Trovato, Claudio Bonifati, Simone Ribero

|Jan 28, 2026
Long-Term Impact of Guselkumab on Systemic Inflammation Indices in Moderate-to-Severe Psoriasis.

Edoardo Mortato, Lorenzo Marcelli, Agostino Panichelli

|Nov 03, 2025
Baricitinib for adult atopic dermatitis: real-world effectiveness, safety, and response predictors.

Niccolò Gori, Lucia Di Nardo, Elena Ippoliti

|Sep 22, 2025
Long-Term Real-World Effectiveness and Drug Survival of Guselkumab in Patients with Psoriasis: A 5-Year Retrospective Study.

Edoardo Mortato, Marina Talamonti, Lorenzo Marcelli

|Jun 27, 2025
Could Disease Duration Influence Response to Dupilumab in Patients With Atopic Dermatitis? A Retrospective Real-Life Study.

Edoardo Mortato, Marina Talamonti, Claudia Paganini

Pageof 7

Frequent Collaborators

37 joint publications

Marco Galluzzo

15 joint publications

Luca Bianchi

5 joint publications

Edoardo Mortato

5 joint publications

Cosimo Di Raimondo